1041525

Gemini Pharmaceuticals, Inc. — FEI 2432926

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Commack, NY (United States)

Citations

IDCFRDescription
119421 CFR 211.42(c)Defined areas of adequate size for operations
356521 CFR 211.58Buildings not maintained in good state of repair
430621 CFR 211.80(a)Written Procedures Not Followed
432821 CFR 211.122(a)Written procedures not followed